Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity

Journal of Neuroscience

Volumn 23, Issue 18, 2003, Pages 7155-7159

  Valentino, Rita J ^a   Bey, Vincent ^a   Pernar, Luise ^a   Commons, Kathryn G ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Anxiety; Dorsal raphe nucleus; Glutamate; Neurokinin 1; Sendide; Serotonin; Substance P

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; KYNURENIC ACID; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; SENDIDE; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG INFUSION; MALE; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SYNAPTIC TRANSMISSION;

EID: 0043127401     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-18-07155.2003     Document Type: Article

References (22)

1. Aghajanian GK, Foote WE, Sheard MH (1968) Lysergic acid diethyl amide: sensitive neuronal units in the midbrain raphe. Science 161:706-708.
2. Aghajanian GK, Foote WE, Sheard MH (1970) Action of psychotogenic drugs on single midbrain raphe neurons. J Pharmacol Exp Ther 171:178-187.
3. Aguiar MS, Brandao ML (1994) Conditioned place aversion produced by microinjections of substance P into the periaqueductal gray of rats. Behav Pharmacol 5:369-373.
4. Aguiar MS, Brandao ML (1996) Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test. Physiol Behav 60:1183-1186.
5. Akaoka H, Saunier C-F, Chergui K, Charlety P, Buda M, Chouvet G (1992) Combining in vivo volume-controlled pressure microejection with extra cellular unit recording. J Neurosci Methods 42:119-128.
6. Commons K, Valentino RJ (2002) Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J Comp Neurol 447:82-97.
7. Commons KG, Connolley KR, Valentino RJ (2003) Anatomical attributes of the dorsomedial raphe nucleus that may underlie a role in affective disorders. Neuropsychopharmacology 28:206-215.
8. Conley RK, Cumberbatch MJ, Mason GS, Williamson DJ, Harrison T, Locker K, Swain CJ, Maubach K, O'Donnell R, Rigby M, Hewson L, Smith D, Rupniak NM (2002) Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity. J Neurosci 22:7730-7736.
9. File SE (1997) Anxiolytic action of a neurokinin 1 receptor antagonist in the social interaction test. Pharmacol Biochem Behav 58:747-752.
10. 1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J Neurosci 21:8188-8197.
11. Gradin K, Qadri F, Nomikos GG, Hillegaart V, Svensson T (1992) Substance P injection into the dorsal raphe increases blood pressure and serotonin release in hippocampus of conscious rats. Eur J Pharmacol 218:363-367.
12. Haddjeri N, Blier P (2001) Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission. Biol Psychiatry 50:191-199.
13. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, et al. (1998) Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640-1645.
14. Liu R, Ding Y, Aghajanian GK (2002) Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus. Neuropsychopharmacology 27:329-340.
15. Maeno H, Kiyama H, Tohyama M (1993) Distribution of substance Preceptor (NK1 receptor) in the central nervous system. Mol Brain Res 18:43-58.
16. Rupniak NM, Kramer MS (1999) Discovery of the antidepressant and antiemetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 20:485-490.
17. Santarelli L, Gobbi G, Debs PC, Sibille EL, Blier P, Hen R, Heath MJS (2001) Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98:1912-1917.
18. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V (2002) The tachykinin peptide family. Pharmacol Rev 54:285-322.
19. Stout SC, Owens MJ, Nemeroff CB (2001) Neurokinin 1 receptor antagonists as potential antidepressants. Annu Rev Pharmacol Toxicol 41:877-906.
20. Swanson LW (1992) Brain maps structure of the rat brain. Amsterdam: Elsevier.
21. Tao R, Auerbach SB (1994) Anesthetics block morphine-induced increases in serotonin release in rat CNS. Synapse 18:307-314.
22. Teixeira RM, Santos AR, Ribeiro SJ, Calixto JB, Rae GA, De Lima TC (1996) Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur J Pharmacol 311:7-14.